Zydus Cadila’s virus vaccine candidate found safe in trial
India’s Zydus Cadila said on Wednesday its Covid-19 vaccine candidate was found to be safe and well-tolerated in an early-stage human trial.
The company will...
PDA writes to GPhC on concerns over apparent failure of pharmacy employers to report coronavirus exposure in workplace
The Pharmacists' Defence Association (PDA) has formally written to the General Pharmaceutical Council (GPhC) over the failure of community pharmacy employers to report any...
MHRA launches emollient fire risk campaign
While dispensing emollients, pharmacists are being asked to highlight fire risks associated with emollients when dried on to fabric.
The Medicines and Healthcare products Regulatory Agency...
DHSC extends medicine supply notification for H2-antagonists
The Department of Health and Social Care (DHSC) has extended a medicine supply notification for H2-antagonists including Cimetidine, Famotidine, and Nizatidine.
The resupply dates of...
Supply alert for Nabumetone 500mg tablets
The Department of Health and Social Care (DHSC) has issued a medicine supply notification for Nabumetone 500mg tablets.
Tilomed Laboratories, the sole suppliers of Nabumetone...
Defect alert for SyreniRing 0.120 mg, 0.015 mg
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class four medicines defect alert for SyreniRing 0.120 mg/0.015 mg per 24 hours,...
Supply alert issued for Senna with ispaghula husk granules Â
The Department of Health and Social Care (DHSC) has issued a medicine supply notification for Senna with ispaghula husk (Manevac) granules (Mylan).
Manevac granules 250g...
DHSC includes ‘new’ pharmacies in Covid-19 advance funding
Recently opened community pharmacies can receive advance funding to help mitigate cashflow issues due to Covid-19 pandemic.
The category of pharmacies include those that had...
Stockpile six weeks’ total stock on UK soil, DHSC tells medicine suppliers; ABPI, RPS respond
Government has asked suppliers to stockpile medicines in anticipation of a no-deal Brexit at the end of the year.
In a letter to medicine suppliers,...
UK risks twice-as-big second Covid-19 wave without better testing
Britain faces a second wave of Covid-19 this winter twice as widespread as the initial outbreak if it reopens schools without a more effective test-and-trace...
Current Issue March 2024
